UPDATE 1-Actavis' superbug antibiotic gets U.S. approval
February 25, 2015 at 19:50 PM EST
Feb 25 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved the use of Actavis Plc's antibiotic, Avycaz, to battle drug-resistant bacteria known as superbugs.
